AdSana

AdSana

Created using Figma
Adsana has developed an effective and affordable Cancer Infusion Therapy that has shown to kill cancer cells and cancer stem cells in dogs and in humans. The Adsana Team intends to establish Treatment Centers to deliver a new low cost, highly effective treatment for cancer.
STO
2019. 9. 1.
2019. 12. 31.
100% 완료된
기금 모금 - 데이터 없음
past
PRE STO
2019. 6. 1.
2019. 9. 1.
100% 완료된
기금 모금 - 데이터 없음
past
추가 세부 사항
카테고리
플랫폼

약 AdSana

THE ADSANA PROJECT

Adsana is launching our SECURITY TOKEN OFFERING and introducing our SANA security token.

This is an opportunity to be involved with an effective and affordable Cancer Infusion Therapy that kills cancer cells and cancer stem cells.

An opportunity to be involved in one of the highest growth industries world wide.  As stated in Science Daily “estimate a 1 percent reduction in mortality from cancer has a value to Americans of nearly $500 billion. A cure for cancer would be worth about $50 trillion.”  

This is not a concept.  This is a real treatment being used now.  Become part of the cancer revolution.

PAYMENT ASSURANCE PROGRAM

Through our Adsana App, a patient or dog owner will be able to pre-pay for the treatment in what we are calling Payment Assurance.  Once payment for services is made, it will be held securely within our decentralized blockchain/holochain platform.  Both the clinic and the patient or dog owner have Payment Assurance the treatment will be performed and the payment will be made.

NETWORK OF TREATMENT CLINICS

Our plan is to transition our Canine Infusion Therapy from a proven treatment for people to a repeatable proven treatment for canine cancer at our Canine Cancer Centers.  We will launch our Canine Cancer Centers first in the United States and then to Europe and Australia.

Projected treatment cost will be  18% to 25% less than typical chemotherapy drug treatments available now for treating cancer in dogs even though existing treatments have a poor prognosis after the treatment. 

ONGOING SCIENTIFIC RESEARCH

As part of Adsana’s continued clinical research, Adsana will store the treatment records for further clinical research. Additionally, Adsana will collect the DNA of the dogs treated.  

Also, as part of the clinic’s services, Adsana will offer DNA collection for all dogs.  Data collected will be stored within Adsana’s decentralized platform.   This data collected will have far-reaching results in treating, tracking and diagnosing of diseases in dogs, especially cancer.

AdSana 팀

검증 됨 17%

주의. 확인되지 않은 회원은 실제로 팀원이 아닌 위험이 있습니다.

Gary D. Nice
Founder and Chief Executive Officer
검증 됨
Russell J. Hall
Chief Operations Officer
확인되지 않음
Dr. Tom S. Tsang
Chief Science Officer
확인되지 않음
Dr. Amanda Beck
DVM, DACVIM (Oncology)
확인되지 않음
Gregory Kennedy
Chief Technical Project Manager
확인되지 않음
Prakash Patel
Graphic Designer
확인되지 않음

고문

검증 됨 0%

주의. 확인되지 않은 회원은 실제로 팀원이 아닌 위험이 있습니다.

Justin Smith
Technical Holochain and AI Advisor
확인되지 않음
Colin Stewart
Technical Advisor
확인되지 않음
Uday Kumar Seethamse...
Technical Advisor and Blockchain Architect
확인되지 않음
Kiran Paturi
Technical Advisor
확인되지 않음
Lance Weisser
Technical Advisor
확인되지 않음

AdSana 인터뷰

GARY D. NICE
As a team member, сan you tell us about your role in the ICO project?
I am the Founder and CEO of AdSana and very proud and excited to bring our treatment to the world. We have an effective, affordable Cancer Infusion Therapy that kills cancer cells in people and dogs. I have been working in cancer research since 2006 as the Founder and President of the National Canine Cancer Foundation.
What do you think about idea?
I am very excited and passionate about our treatment. How effective it is and how inexpensive it is. How can you not be excited when we kill cancer cells, so cancer is no longer a fatal disease.

AdSana 최근 뉴스

  • 정보 업데이트에는 시간차가있을 수 있으므로 각 ICO 프로젝트에 대한 정확한 정보는 공식 웹 사이트 또는 기타 커뮤니케이션 채널을 통해 확인해야합니다.
  • 이 정보는 ICO 기금 투자에 대한 제안이나 조언이 아닙니다. 관련 정보를 철저히 조사하고 ICO 참여를 결정하십시오.
  • 이 콘텐츠에 대해 수정해야 할 문제 또는 문제가 있다고 생각되거나 자신의 ICO 프로젝트를 제출하고자 할 경우 이메일을 보내주십시오. a>
면책 조항 및 위험 경고를 읽으십시오. 면책 조항 및 위험 경고 표시.